3Jenner P. Oxidative stress in Parkinson' s disease. Ann Neural, 2003,53 Suppl 3 :S26-S38. 被引量：1
4Hink HU, Santanam N, Dikalov S, et al. Peroxidase properties of extraceUular superoxide dismutase:role of uric acid in modulating in vivo activity. Arterioscler Thromb Vasc Biol, 2002,22 : 1402- 1408. 被引量：1
5Duan W, Ladenheim B, Cutler RG, et al. Dietary folate deficiency and elevated homocysteine levels endanger dopaminergic neurons in models of Parkinson' s disease. J Neurochem, 2002, 80 : 101-110. 被引量：1
6Fitzmaurice PS, Ang L, Guttman M, et al. Nigral glutathione deficiency is not specific for idiopathic Parkinson' s disease. Mov Disord, 2003,18:969-976. 被引量：1
7Meara J, Bhowmick BK, Hobson P. Accuracy of diagnosis in patients with presumed Parkinson' s disease. Age Ageing, 1999, 28 : 99-102. 被引量：1
8Church WH,Ward VL Uric acid is reduced in the substantia nigra in Parkinsen' s disease: effect on dopamine oxidation. Brain Res Bull,1994, 33: 419-425. 被引量：1
9Kim TS, Pae CU, Yoon SJ, et al. Decreased plasma antioxidants in patients with Alzheimer' s disease. Int J Geriatr Psychiatry, 2006,21:344-348. 被引量：1
10Rentzos M, Nikolaou C, Anagnostouli M, et al. Serum uric acid and multiple sclerosis. Clin Neurol Neurosurg, 2006, 108 : 527- 531. 被引量：1
